Senate bill aims to rebuild drug manufacturing infrastructure: 3 notes

Eileen Cook June 18, 2025June 18, 2025 Drug Manufacturing, Drug Shortages, Healthcare Finance, The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act

(By: Alexandra Murphy for Becker’s Hospital Review)

A bipartisan group of U.S. senators has reintroduced a bill designed to address ongoing shortages of generic drugs by expanding domestic stockpiles and manufacturing capacity. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.